Advisory Commission on Childhood Vaccines; Notice of Meeting, 29197 [2014-11648]

Download as PDF Federal Register / Vol. 79, No. 98 / Wednesday, May 21, 2014 / Notices Email address: infocollection@ acf.hhs.gov. All requests should be identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Robert Sargis, Reports Clearance Officer. [FR Doc. 2014–11660 Filed 5–20–14; 8:45 am] BILLING CODE 4184–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission on Childhood Vaccines; Notice of Meeting mstockstill on DSK4VPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: June 5, 2014, 10:00 a.m. to 4:00 p.m. (Eastern Daylight Time). Place: The meeting will be via audio conference call and Adobe Connect Pro. Status: The meeting will be open to the public. Agenda: The agenda items for the June meeting will include, but are not limited to: Updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV Web site (https:// www.hrsa.gov/vaccinecompensation/ accv.htm) prior to the meeting. Agenda items are subject to change as priorities dictate. The public can join the meeting by: 1. (Audio Portion) Calling the conference number at 877–917–4913 and providing the Leader’s Name, Dr. A. Melissa Houston, AND Password, ACCV; AND VerDate Mar<15>2010 17:42 May 20, 2014 Jkt 232001 2. (Visual Portion) Connecting to the ACCV Adobe Connect Pro Meeting using the following URL, and entering as GUEST: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if the link does not work directly, and enter as a guest). Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connectsolutions.com/ common/help/en/support/meeting_test.htm and get a quick overview by following URL: https://www.adobe.com/go/connectpro_ overview. Call (301) 443–6634 or send an email to aherzog@hrsa.gov if you are having trouble connecting to the meeting site. Public Comment: It is preferred that persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857 or email at aherzog@hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by email, mail, or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the public comment period. Public participation and ability to comment will be limited to space and time as it permits. For Further Information Contact: Annie Herzog, DVIC, HSB, HRSA, Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443–6593; email aherzog@ hrsa.gov. Dated: May 15, 2014. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2014–11648 Filed 5–20–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 29197 provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group, NHLBI Institutional Training Mechanism Review Committee. Date: June 19–20, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Marriott/Courtyard Chevy Chase, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Charles Joyce, Ph.D. Scientific Review Officer, Office of Scientific Review/DERA National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892–7924, 301–435– 0288, cjoyce@nhlbi.nih.gov. Name of Committee: Heart, Lung, and Blood Initial Review Group, Heart, Lung, and Blood Program Project Review Committee. Date: June 20, 2014. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jeffrey H. Hurst, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7208, Bethesda, MD 20892, 301–435–0303, hurstj@ nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute, Special Emphasis Panel, Atherosclerosis and Structure and Function of HDL. Date: June 20, 2014. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Washington, DC/ Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: YingYing Li-Smerin, MD, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD 20892– 7924, 301–435–0275, lismerin@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute, Special Emphasis Panel, Mentoring Programs to Promote Diversity in Health Research. Date: June 23, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Washington, DC Dupont Circle Hotel, 1143 New Hampshire Avenue NW. Washington, DC 20037. E:\FR\FM\21MYN1.SGM 21MYN1

Agencies

[Federal Register Volume 79, Number 98 (Wednesday, May 21, 2014)]
[Notices]
[Page 29197]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11648]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), notice is hereby given of the 
following meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: June 5, 2014, 10:00 a.m. to 4:00 p.m. (Eastern 
Daylight Time).
    Place: The meeting will be via audio conference call and Adobe 
Connect Pro.
    Status: The meeting will be open to the public.
    Agenda: The agenda items for the June meeting will include, but 
are not limited to: Updates from the Division of Vaccine Injury 
Compensation (DVIC), Department of Justice, National Vaccine Program 
Office, Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health), and Center for Biologics, 
Evaluation and Research (Food and Drug Administration). A draft 
agenda and additional meeting materials will be posted on the ACCV 
Web site (https://www.hrsa.gov/vaccinecompensation/accv.htm) prior to 
the meeting. Agenda items are subject to change as priorities 
dictate.
    The public can join the meeting by:
    1. (Audio Portion) Calling the conference number at 877-917-4913 
and providing the Leader's Name, Dr. A. Melissa Houston, AND 
Password, ACCV; AND
    2. (Visual Portion) Connecting to the ACCV Adobe Connect Pro 
Meeting using the following URL, and entering as GUEST: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your 
browser if the link does not work directly, and enter as a guest).
    Participants should call and connect 15 minutes prior to the 
meeting in order for logistics to be set up. If you have never 
attended an Adobe Connect meeting, please test your connection using 
the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by following URL: 
https://www.adobe.com/go/connectpro_overview.
    Call (301) 443-6634 or send an email to aherzog@hrsa.gov if you 
are having trouble connecting to the meeting site.
    Public Comment: It is preferred that persons interested in 
providing an oral presentation should submit a written request, 
along with a copy of their presentation to: Annie Herzog, DVIC, 
Healthcare Systems Bureau (HSB), Health Resources and Services 
Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville, MD 
20857 or email at aherzog@hrsa.gov. Requests should contain the 
name, address, telephone number, email address, and any business or 
professional affiliation of the person desiring to make an oral 
presentation. Groups having similar interests are requested to 
combine their comments and present them through a single 
representative.
    The allocation of time may be adjusted to accommodate the level 
of expressed interest. DVIC will notify each presenter by email, 
mail, or telephone of their assigned presentation time. Persons who 
do not file an advance request for a presentation, but desire to 
make an oral statement, may announce it at the time of the public 
comment period. Public participation and ability to comment will be 
limited to space and time as it permits.
    For Further Information Contact: Annie Herzog, DVIC, HSB, HRSA, 
Room 11C-26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 
443-6593; email aherzog@hrsa.gov.

    Dated: May 15, 2014.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2014-11648 Filed 5-20-14; 8:45 am]
BILLING CODE 4165-15-P